Marshall Wace’s Sight Sciences SGHT Stock Holding History

Marshall Wace’s Portfolio SGHT Stock Details SGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$262K	Buy	69,473 +29,520	+74%	+$159K	﹤0.01%	2696
2025 Q4	$317K	Buy	+39,953	New	+$255K	﹤0.01%	2429
2025 Q1	–	Sell	-26,300	Closed	-$95.7K	–	3046
2024 Q4	$95.7K	Buy	+26,300	New	+$120K	﹤0.01%	2446
2024 Q1	–	Sell	-47,513	Closed	-$245K	–	2775
2023 Q4	$245K	Buy	+47,513	New	+$147K	﹤0.01%	1927
2022 Q1	–	Sell	-100	Closed	-$1K	–	3948
2021 Q4	$1K	Buy	+100	New	+$2.19K	﹤0.01%	3797

Other funds holding SGHT

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Marshall Wace's SGHT Position: Q1 2026 in Review

Marshall Wace increased its Sight Sciences (SGHT) stake by 74% in Q1 2026, buying an estimated $159K and bringing the position to 69,473 shares worth $262K. The position accounts for ﹤0.01% of the portfolio, ranked #2696.

Marshall Wace first reported a position in SGHT in Q4 2021 and has held it in 5 quarters since. The position peaked at $317K in Q4 2025. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

Marshall Wace held 69,473 shares of Sight Sciences worth $262K as of Q1 2026.
Marshall Wace bought 29,520 Sight Sciences shares in Q1 2026, an estimated $159K.
Sight Sciences made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2696 holding.
Marshall Wace first reported a position in Sight Sciences in Q4 2021 and has held it in 5 quarters since.
Marshall Wace's Sight Sciences position peaked at $317K in Q4 2025.
114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.